ivWatch, LLC

ivWatch, LLC Our mission is bold and clear: STOP IV HARM. Continuous monitors exist to keep track of patients’ heart, blood oxygen levels and pulse rates.

ivWatch is redefining IV therapy safety with the only FDA-cleared and CE-marked medical device in the world designed to detect IV infiltrations and extravasations early, before they cause patient harm. ivWatch, LLC is a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy. IV therapy is a basic yet critical component of care in hospital and outpatient settings, but it has a high failure rate. Until now, no technology has been available to continuously monitor the health of a patient’s IV site, and whether drugs or fluids are being delivered through the vein or leaking into the tissue. The ivWatch Model 400 is a FDA-cleared device to help clinicians monitor the status of a patient’s IV to aid in the early detection of peripheral IV infiltrations and extravasations. Through the use of non-invasive sensor technology, the ivWatch Model 400 can help reduce potentially serious medication dosing errors and associated patient harm from infiltration events. A continuously monitored peripheral IV also offers an alternative to more intrusive vascular access devices when medically indicated. Use of these devices has increased, but can also pose significant risk of harm to patients and greater cost and liability for hospitals. ivWatch has the potential to transform IV therapy by improving patient care and safety, and offering health care providers a much-needed, reliable and cost-effective solution for continuously monitoring peripheral IVs.

THE IV SAFETY MOVEMENT IS GAINING MOMENTUMThe energy at the 2026 IV Therapy Summit was unmistakable, as clinicians unite...
02/19/2026

THE IV SAFETY MOVEMENT IS GAINING MOMENTUM

The energy at the 2026 IV Therapy Summit was unmistakable, as clinicians united around a shared priority: preventing avoidable harm from infiltration and extravasation injuries.

Through stronger alignment with national standards and better support for frontline clinicians in early detection and intervention, IV safety is moving beyond discussion into action. What was once a local hospital priority is now embedded as an NHS standard. The transition from reactive response to proactive prevention marks a powerful and necessary shift in patient safety culture.

ivWatch isn’t just a product—it’s a long-term commitment.Beyond precision IV safety technology, our clinical experts pro...
02/18/2026

ivWatch isn’t just a product—it’s a long-term commitment.

Beyond precision IV safety technology, our clinical experts provide continuous, hands-on support to help facilities sustain and advance IV therapy quality over time. From education to workflow integration, we work alongside clinicians to drive lasting improvement.

Our support is tailored to each facility and includes:
• Superuser training
• In-service days
• Clinical rounding
• Educational workshops
• Digital learning modules
• Study days and staff development sessions

We’re here to elevate IV therapy standards, strengthen clinical confidence, and improve patient safety—today and long term.

For too long, IV safety has relied on “wait and see”—and patients pay the price. IV extravasation remains a persistent y...
02/17/2026

For too long, IV safety has relied on “wait and see”—and patients pay the price.

IV extravasation remains a persistent yet preventable source of harm across healthcare.

It’s time to challenge the status quo:
• Do infusion protocols match today’s clinical risks?
• Are nurses equipped with training that goes beyond outdated practices?
• Is continuous surveillance technology that detects IV failure before it’s visible put into practice?

Awareness isn’t enough. Prevention requires action.

It’s time to move forward—and stop IV extravasations before harm occurs.

Learn more about IV surveillance technology : https://www.ivwatch.com/tech-overview/

02/17/2026

EDUCATION ALERT!
Hear from expert Andrew Barton, Nurse Consultant in IV Therapy & Vascular Access and NIVAS Lead Nurse as he shared insights on the five causes of IV infiltration and extravasation—and why many clinicians aren’t aware of them. These hidden risks reinforce why education is critical.

At ivWatch, we’re committed to providing educational tools for clinicians because we’re on a mission to stop IV harm.

Read more about the causes:
https://www.ivwatch.com/2025/01/16/ivs-fail-too-often/

ivWatch is on the move.We’re teaming up with healthcare leaders who refuse to accept reactive IV care.Our mission is sim...
02/12/2026

ivWatch is on the move.

We’re teaming up with healthcare leaders who refuse to accept reactive IV care.
Our mission is simple: stop avoidable IV harm and raise the bar for IV therapy.

With real-time insight and early detection, clinicians can act sooner—when it matters most.

More cities. More impact. Stay tuned.

Not long ago, extravasations were brushed off as unavoidable complications. Today, hospitals have committees, policies, ...
02/11/2026

Not long ago, extravasations were brushed off as unavoidable complications. Today, hospitals have committees, policies, and antidotes—but clinicians are still reacting after patients are harmed.

Peripheral IV injuries aren’t confined to oncology or critical care, and they are not rare. They’re hospital-acquired events happening across every unit, often from medications we underestimate. Antidotes may limit damage, but they don’t prevent it. If harm has already occurred, prevention has already failed.

Read the full article to examine why relying on antidotes—such as hyaluronidase, phentolamine, nitroglycerin, or sodium thiosulfate—means we’re already too late, and how hospitals can shift severe extravasation injuries from treatment to true prevention. https://www.ivwatch.com/2026/02/09/antidotes-arent-prevention-why-hospitals-are-still-losing-the-pivie-fight/

02/10/2026

ivWatch is redefining IV therapy safety. The world’s only continuous IV monitoring system is clinically proven to detect infiltration and extravasation events before visible signs appear, ivWatch helps prevent severe IV harm before it happens.

Backed by decades of research and clinical validation, ivWatch continuously monitors IV site integrity in high-risk care settings. IV therapy is one of the most common procedures in healthcare, yet studies show up to 50% of IVs fail before treatment is complete, resulting in pain, tissue injury, prolonged hospital stays, and higher costs.

Using a non-invasive sensor technology and a predictive algorithm, ivWatch empowers clinical teams to intervene early, improve patient outcomes, reduce liability, and drive cost savings—setting a new standard of care for IV therapy.

Our mission is bold: STOP IV HARM.

Watch the video and schedule a demo to see ivWatch in action: https://www.ivwatch.com/request-a-demo/



Melissa went into routine surgery and left facing a life-changing IV injury.Years of surgeries and the loss of part of h...
02/05/2026

Melissa went into routine surgery and left facing a life-changing IV injury.

Years of surgeries and the loss of part of her hand reshaped her life, her career, and how she shows up for her son.

Stories like Melissa’s give our mission a human face—turning advocacy into purpose and reminding us that this work exists to protect real people.

Her voice reinforces why early detection matters and why safer IV care is non-negotiable.

Read full Melissa’s story here:
https://www.ivwatch.com/2024/10/03/a-preventable-iv-injury-changed-an-artists-life-forever/

All patients worldwide who receive IV therapy are at inherent risk of infiltration or extravasation. Advancing IV safety...
02/03/2026

All patients worldwide who receive IV therapy are at inherent risk of infiltration or extravasation. Advancing IV safety requires challenging the current standard and evolving with new best practices, learnings, and evidence-based innovation.

Join us and commit to advancing clinical excellence, and enhancing patient safety:https://www.ivwatch.com/

02/03/2026

In this video, you’ll see how extravasations can occur—even in the most experienced hands; learn why you can’t rely on a “good” flush alone.

Clinical practice evolves when long-held assumptions are challenged—such as the belief that blood return and an easy flush confirm a healthy IV.

In reality, some infiltrations are still present with both—delaying recognition and increasing patient risk.

IV infiltrations and extravasations impact every patient population, from neonates to geriatrics, and can lead to dosing errors, skin necrosis, nerve damage, skin staining, and even amputation.

Real-time IV monitoring enables proactive detection—often before visible signs appear.

Learn more about the technology to stop IV harm: https://www.ivwatch.com/tech-overview/

IV nurses continuously refine their expertise to navigate complex and often unpredictable vascular access—caring for som...
01/29/2026

IV nurses continuously refine their expertise to navigate complex and often unpredictable vascular access—caring for some of the most vulnerable patients while administering high-risk medications where precision is critical and there’s no room for error.

This IV Nurses Week, we honor the clinicians who balance technical mastery with deep compassion, who advocate relentlessly for patient safety, and who embrace innovations like ivWatch to add another layer of protection when the margin for risk is razor thin. They don’t just manage IVs—they safeguard trust, comfort, and lives.

One of the biggest—and most underreported—problems in healthcare happens every day around the globe: IV infiltration and...
01/29/2026

One of the biggest—and most underreported—problems in healthcare happens every day around the globe: IV infiltration and extravasation events.

Across all patient populations and care settings, IV complications often go undetected until visible harm occurs and it’s too late to change outcomes.

At ivWatch, we stand to eliminate IV injury harm. It’s time to intervene sooner, reduce litigation and risk, and avoid costly IV injury care.

Learn more: https://www.ivwatch.com/tech-overview/

Address

700 Tech Center Parkway, Suite 300
Newport News, VA
23606

Opening Hours

Monday 8:30am - 6pm
Tuesday 8:30am - 6pm
Wednesday 8:30am - 6pm
Thursday 8:30am - 6pm
Friday 8:30am - 6pm

Alerts

Be the first to know and let us send you an email when ivWatch, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ivWatch, LLC:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

ivWatch, LLC is a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy. IV therapy is a basic yet critical component of care in hospital and outpatient settings, but it has a high failure rate. Continuous monitors exist to keep track of patients’ heart, blood oxygen levels and pulse rates. Until now, no technology has been available to continuously monitor the health of a patient’s IV site, and whether drugs or fluids are being delivered through the vein or leaking into the tissue. The ivWatch Model 400 is a FDA-cleared device to help clinicians monitor the status of a patient’s IV to aid in the early detection of peripheral IV infiltrations and extravasations. Through the use of non-invasive sensor technology, the ivWatch Model 400 can help reduce potentially serious medication dosing errors and associated patient harm from infiltration events. A continuously monitored peripheral IV also offers an alternative to more intrusive vascular access devices when medically indicated. Use of these devices has increased, but can also pose significant risk of harm to patients and greater cost and liability for hospitals. ivWatch has the potential to transform IV therapy by improving patient care and safety, and offering health care providers a much-needed, reliable and cost-effective solution for continuously monitoring peripheral IVs.